CONSTITUENT REPORT
Palmitic acid
Palmitic acid is one of the most common saturated fatty acids in plant and animal lipids and appears across several AromaForge carrier-oil records as a routine fatty-acid component rather than a trace specialty constituent. The strongest public evidence supports identity, widespread occurrence, cosmetic-safety context, and basic mechanistic biology. Palmitic acid also has a large biomedical literature, but much of it concerns dietary, metabolic, or cell-culture exposure models rather than aroma-style topical use, so AromaForge should present it as a structural lipid constituent with context-specific preclinical findings rather than as a wellness claim ingredient.
Chemical identity and composition
PubChem identifies palmitic acid as C16H32O2 with InChIKey IPCSVZSSVZVIGE-UHFFFAOYSA-N and IUPAC name hexadecanoic acid. CAS Common Chemistry lists CAS 57-10-3 and molecular mass 256.42. In the local archive it is a recurring carrier-oil fatty acid, including about 4.42% in camellia seed oil, 11.5% in pumpkin seed oil, and a listed 2-10% range in moringa oil.
Aroma and practical use
- Use the recorded waxy, fatty, oily, soft descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2019 human skin-equivalent study reported that reducing supplemented palmitic acid delayed early differentiation and increased epidermal activation, supporting a role for palmitic acid in epidermal morphogenesis and lipid barrier formation.
A 2019 human skin-equivalent study reported that reducing supplemented palmitic acid delayed early differentiation and increased epidermal activation, supporting a role for palmitic acid in epidermal morphogenesis and lipid barrier formation.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2019 inflammatory review concluded that palmitic acid can promote macrophage inflammatory responses through mechanisms involving ER stress, ROS generation, PKC activation, and strengthened NF-kB-related signaling, highlighting a strong preclinical inflammation literature.
A 2019 inflammatory review concluded that palmitic acid can promote macrophage inflammatory responses through mechanisms involving ER stress, ROS generation, PKC activation, and strengthened NF-kB-related signaling, highlighting a strong preclinical inflammation literature.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A modern CIR/FDA-hosted safety assessment for fatty acids and fatty acid salts reports no primary or cumulative irritation or sensitization in human repeated-insult patch tests for cosmetic formulations containing palmitic acid within reviewed concentration ranges, while also noting generally low acute toxicity and no human photosensitization signal for formulations containing palmitic acid.
A modern CIR/FDA-hosted safety assessment for fatty acids and fatty acid salts reports no primary or cumulative irritation or sensitization in human repeated-insult patch tests for cosmetic formulations containing palmitic acid within reviewed concentration ranges, while also noting generally low acute toxicity and no human photosensitization signal for formulations containing palmitic acid.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
recorded reference · CIR Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid (1987), J. Am. Coll. Toxicol. 6(3):321-401, DOI 10.3109/10915818709098563 - abstract states cosmetic formulations containing Palmitic Acid at concentrations up to 13% were not primary or cumulative irritants nor sensitizersScreening assumption (verified). It is not a verified constituent-specific exposure limit.
model fallback · CIR Final Report on the Safety Assessment of Oleic Acid, Lauric Acid, Palmitic Acid, Myristic Acid, and Stearic Acid (1987), J. Am. Coll. Toxicol. 6(3):321-401, DOI 10.3109/10915818709098563 - abstract states cosmetic formulations containing Palmitic Acid at concentrations up to 13% were not primary or cumulative irritants nor sensitizersCosmetic-review literature is materially stronger than aromatherapy-style dosing literature for palmitic acid and generally describes low acute toxicity with limited irritation or sensitization concerns in tested cosmetic formulations.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
The FDA-hosted CIR review states that cosmetic product formulations containing palmitic acid in the reviewed range produced no photosensitization in human subjects.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Much of the higher-profile risk literature around palmitic acid concerns dietary or metabolic exposure contexts rather than topical exposure from cosmetic oils, so those findings should not be collapsed into simple topical hazard claims.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
Linoleic acidAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
food chemistry · antioxidant
No source citation attached.
Read Linoleic acid report →How the effects were investigated
skin barrier lipid support
Human skin-equivalent work indicates palmitic acid contributes to epidermal morphogenesis and lipid barrier formation, supporting its role as a structural free-fatty-acid component in barrier biology.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
pro inflammatory signaling in macrophage models
Mechanistic reviews of macrophage studies describe palmitic acid as capable of amplifying inflammatory signaling through ER-stress, ROS, PKC, and NF-kB-related pathways, often in conjunction with TLR4-linked models; this literature is substantial but not directly transferable to topical aromatics use.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Palmitic acid has abundant biomedical literature, but much of it is dietary or metabolic rather than directly relevant to topical essential-oil use.
- This pass did not verify an AromaForge-style dermal maximum specific to palmitic acid as a standalone constituent; the 25% figure is not sourced to a specific IFRA/RIFM numeric ceiling and should be read as a working carrier-oil-context value rather than a regulatory limit.
- Because palmitic acid is a common structural lipid, constituent-specific claims need context discipline to avoid over-translating cell or disease-model findings.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.